La chloroquine/Hydroxychloroquine pour le traitement de la COVID-19

Publications Scientifiques en Anglais

Dernière mise à jour : 16/04/2020

[Clin Pharmacokinet. 18 avril 2020] - Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties. PubMed ID : 32306288
[Clin Pharmacol Ther. 17 avril 2020] - Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19. PubMed ID : 32302411
[Clin Med (Lond). 17 avril 2020] - Chloroquine and COVID-19 - a potential game changer?. PubMed ID : 32303497
[Clin Pharmacol Ther. 14 avril 2020] - Optimizing hydroxychloroquine dosing for patients with COVID-19: An integrative modeling approach for effective drug repurposing. PubMed ID : 32285930
[FASEB J. 13 avril 2020] - Existing bitter medicines for fighting 2019-nCoV-associated infectious diseases. PubMed ID : 32281695
[Biosci Trends. 13 avril 2020] - Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19). PubMed ID : 32281583
[J Am Acad Dermatol. 10 avril 2020] - Does Hydroxychloroquine Combat COVID-19? A Timeline of Evidence. PubMed ID : 32283236
[Clin Rheumatol. 10 avril 2020] - Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. PubMed ID : 32277367
[Science. 10 avril 2020] - Would-be coronavirus drugs are cheap to make. PubMed ID : ---
[Ann Intern Med. 9 avril 2020] - Annals On Call - COVID-19: Is Chloroquine the Answer?. PubMed ID : 32271869
[Science. 9 avril 2020] - Is France's president fueling the hype over an unproven coronavirus treatment?. PubMed ID : ---
[Nat Med. 6 avril 2020] - Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus. PubMed ID : 32269358
[BMJ. 8 avril 2020] - Chloroquine and hydroxychloroquine in covid-19. PubMed ID : 32269046
[CMAJ. 8 avril 2020] - Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. PubMed ID : 32269021
[Balkan Med J. 8 avril 2020] - Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon. PubMed ID : 32264666
[Drug Saf. 8 avril 2020] - Chloroquine for COVID-19 Infection. PubMed ID : 32266694
[J Rheumatol. 8 avril 2020] - Possible Consequences of a Shortage of Hydroxychloroquine for Lupus Patients Amid the COVID-19 Pandemic. PubMed ID : 32269064
[Preprint. 8 avril 2020] - Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine to Win Todays Battle Against COVID-19?. PubMed ID : ---
[BJGP Open. 7 avril 2020] - Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review.. PubMed ID : 32265182
[Drug Saf. 7 avril 2020] - Chloroquine for COVID-19 Infection. PubMed ID : 32266694
[Clin Infect Dis. 7 avril 2020] - Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients. PubMed ID : 32255489
[Dermatol Ther. 7 avril 2020] - A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?. PubMed ID : 32259878
[J Biol Regul Homeost Agents. 7 avril 2020] - Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. PubMed ID : 32253888
[Cureus. 6 avril 2020] - A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). PubMed ID : 32269893
[Rev Soc Bras Med Trop. 6 avril 2020] - Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes. PubMed ID : 32267301
[Biosci Trends. 4 avril 2020] - Macrolide treatment for COVID-19: Will this be the way forward?. PubMed ID : 32249257
[Clin Pharmacol Ther. 4 avril 2020] - Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection. PubMed ID : 32246834
[Biorxiv. 4 avril 2020] - Fatal toxicity of chloroquine or hydroxychloroquine with metformin in mice. PubMed ID : ---
[Am J Trop Med Hyg. 3 avril 2020] - A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19). PubMed ID : 32247318
[Int J Antimicrob Agents. 3 avril 2020] - Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. PubMed ID : 32251731
[Clin Pharmacol Ther. 3 avril 2020] - Chloroquine: Can it be a Novel Drug for COVID-1. PubMed ID : ---
[J Cardiovasc Pharmacol. 2 avril 2020] - Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19). PubMed ID : 32282502
[Clin Toxicol (Phila). 2 avril 2020] - Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution. PubMed ID : 32237918
[J Rheumatol. 2 avril 2020] - Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic. PubMed ID : 32241801
[Ann Rheum Dis. 2 avril 2020] - To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic. PubMed ID : 32241791
[Chemrxiv. 2 avril 2020] - Signal Amplification by Reversible Exchange for COVID-19 Antiviral Drug Candidates. PubMed ID : ---
[Int J Infect Dis. 1 avril 2020] - Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV. PubMed ID : 32247050
[J Chin Med Assoc. 1 avril 2020] - Potential therapeutic agents against COVID-19: What we know so far. PubMed ID : 32243270
[J Mol Cell Biol. 1 avril 2020] - Treating COVID-19 with Chloroquine. PubMed ID : 32236562
[J Mol Cell Biol. 1 avril 2020] - Combating COVID-19 with Chloroquine. PubMed ID : 32236561
[BMJ. 1 avril 2020] - Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence. PubMed ID : 32238355
[Ann Intern Med. 31 mars 2020] - Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know. PubMed ID : 32232419
[Monaldi Arch Chest Dis. 31 mars 2020] - Chloroquine in COVID-19: the evidence. PubMed ID : 32231349
[biorxiv. 31 mars 2020] - Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells. PubMed ID : ---
[Aging (Albany NY). 30 mars 2020] - COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?. PubMed ID : 32229706
[Monaldi Arch Chest Dis. 30 mars 2020] - Emerging prophylaxis strategies against COVID-19. PubMed ID : 32231348
[Ann Intern Med. 30 mars 2020] - A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. PubMed ID : 32227189
[Cell Res. 30 mars 2020] - Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. PubMed ID : 32020029
[Rheumatol Int. 30 mars 2020] - Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs. PubMed ID : 32232552
[Int J Antimicrob Agents. 28 mars 2020] - The epidemiology, diagnosis and treatment of COVID-19. PubMed ID : 32234468
[Am J Nephrol. 28 mars 2020] - A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease. PubMed ID : 32222713
[JAMA Cardiol. 27 mars 2020] - Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). PubMed ID : 32219357
[Med Mal Infect. 27 mars 2020] - Chloroquine and COVID-19, where do we stand?. PubMed ID : 32217166
[Science. 27 mars 2020] - Race to find COVID-19 treatments accelerates. PubMed ID : 32217705
[Diabetes Metab Syndr. 26 mars 2020] - Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. PubMed ID : 32247211
[AJ Med Virol. 26 mars 2020] - Controversial treatments: an updated understanding of the Coronavirus Disease 2019. PubMed ID : 32219882
[Am J Ophthalmol. 25 mars 2020] - COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern? PubMed ID : 32247518
[Am J Trop Med Hyg. 25 mars 2020] - Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc). PubMed ID : 32247213
[Fa Yi Xue Za Zhi. 25 mars 2020] - The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 (COVID-19) and Its Research Progress in Forensic Toxicology. PubMed ID : 32212513
[Clin Infect Dis. 24 mars 2020] - Could chloroquine/hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment?. PubMed ID : 32211771
[N Engl J Med. 23 mars 2020] - Fair Allocation of Scarce Medical Resources in the Time of Covid-19. PubMed ID : 32202722
[Am J Obstet Gynecol. 23 mars 2020] - Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy. PubMed ID : 32217113
[Nat Nanotechnol. 23 mars 2020] - Insights from nanomedicine into chloroquine efficacy against COVID-19. PubMed ID : 32203437
[Pain Physician. 23 mars 2020] - Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use. PubMed ID : 32214286
[BMJ. 23 mars 2020] - Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence. PubMed ID : 32205321
[Int J Antimicrob Agents. 20 mars 2020] - Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. PubMed ID : 32205204
[J Antimicrob Chemother. 20 mars 2020] - COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. PubMed ID : 32203437
[Rev Panam Salud Publica. 20 mars 2020] - Clinical trials on drug repositioning for COVID-19 treatment. PubMed ID : 32256547
[N Engl J Med. 19 mars 2020] - Audio Interview: New Research on Possible Treatments for Covid-19. PubMed ID : 32187489
[Cell Discov. 18 mars 2020] - Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. PubMed ID : 32194981
[N Engl J Med. 18 mars 2020] - Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line. PubMed ID : 32187459
[Int J Antimicrob Agents. 17 mars 2020] - Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine. PubMed ID : 32194152
[Preprints. 17 mars 2020] - Chloroquine as a Potential Treatment and Prevention Measure for the 2019 Novel Coronavirus: A Review. PubMed ID : 32194152
[Biosci Trends. 16 mars 2020] - Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. PubMed ID : 32074550
[Biosci Trends. 16 mars 2020] - COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern. PubMed ID : 32092748
[Int J Antimicrob Agents. 13 mars 2020] - Teicoplanin: an alternative drug for the treatment of COVID-19?. PubMed ID : 32179150
[Int J Antimicrob Agents. 12 mars 2020] - New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?. PubMed ID : 32171740
[J Crit Care. 10 mars 2020] - A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. PubMed ID : 32173110
[Clin Infect Dis. 9 mars 2020] - In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). PubMed ID : 32150618
[Drug Discov Ther. 14 mars 2020] - Discovering drugs to treat coronavirus disease 2019 (COVID-19). PubMed ID : 32147628
[Antiviral Res. 5 mars 2020] - Of chloroquine and COVID-19. PubMed ID : 32147496
[J Microbiol Immunol Infect. 4 mars 2020] - Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. PubMed ID : 32173241
[Int J Antimicrob Agents. 4 mars 2020] - Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. PubMed ID : 32145363
[Int J Antimicrob Agents. 15 février 2020] - Chloroquine for the 2019 novel coronavirus SARS-CoV-2. PubMed ID : 32070753
[J Microbiol Immunol Infect. 7 février 2020] - Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. PubMed ID : 32173241

Publications Scientifiques en Français

[Rev Med Suisse. 8 avril 2020] - Miscellanées coronavirales, politiques et médicamenteuses. PubMed ID : 32270943
[Rev Med Suisse. 8 avril 2020] - Covid-19, dans les brouillards français de l'hydroxychloroquine. PubMed ID : 32270942
[Rev Med Suisse. 23 mars 2020] - Epidémie de coronavirus et polémique sur la chloroquine. PubMed ID : 32167254
[Rev Med Suisse. 11 mars 2020] - Covid-19 : essai clinique européen ; éthique pharmaceutique. PubMed ID : 32216186

Publications Scientifiques en Allemand

[Dtsch Med Wochenschr. 9 avril 2020] - [COVID-19 Crisis: Early Observations on a Pandemic's Psychiatric Problems]. PubMed ID : 32274787

Publications Scientifiques en Chinois

[Zhonghua Jie He He Hu Xi Za Zhi. 12 mars 2020] - [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. PubMed ID : 32164085
[Zhonghua Jie He He Hu Xi Za Zhi. 24 février 2020] - [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].. PubMed ID : 32075365

Presse Scientifiques

Dernière mise à jour : 16 avril 2020

[Quotidien du Médecin 9 avril 2020] - Covid-19 : Macron rend une visite surprise au Pr Raoult, à l'origine d'un traitement controversé.
[Quotidien du Médecin 27 mars 2020] - « Chloroquine : faut-il l'utiliser contre le Covid-19? » Le oui, mais d'un biologiste.

Dernière mise à jour : 16 avril 2020

Académies & Sociétés Savantes

[Académies nationales de Médecine et de Pharmacie - 26 mars 2020] - Communiqué des Académies nationales de Médecine et de Pharmacie sur les traitements à base d'hydroxychloroquine dans le cadre de la pandémie de COVID-19 .

OMS

[OMS - 9 avril 2020] - Medical Product Alert Nº4/2020.

Gouvernement Français

[Le Gouvernement Français - 25 mars 2020] - Décret nº 2020-314 du 25 mars 2020 complétant le décret nº 2020-293 du 23 mars 2020 prescrivant les mesures générales nécessaires pour faire face à l'épidémie de covid-19 dans le cadre de l'état d'urgence sanitaire.

Gouvernement Britannique

[Medicines and Healthcare products Regulatory Agency (MHRA) - 25 mars 2020] - Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment.

Industrie Pharmaceutique

[SANOFI - 10 avril 2020] - Communiqué de presse : COVID-19 : Sanofi fait don de 100 millions de doses d'hydroxychloroquine à 50 pays.

Presse Généraliste nationale et internationale

Dernière mise à jour : 16 avril 2020

Presse Francophone

[Les Echos - 8 avril 2020] - Covid-19 : la Chloroquine, le médicament qui divise le monde scientifique.
[The Conversation - 6 avril 2020] - Chloroquine et infections virales : ce qu'il faut savoir.

Presse Anglophone

[The New York Times - 12 avril 2020] - Small Chloroquine Study Halted Over Risk of Fatal Heart Complications.
[The Guardian - 25 mars 2020] - Chloroquine: Trump's misleading claims spark hoarding and overdose.

Presse Arabophone

[Alkhabar (Algérie) - 5 avril 2020] - [Les premiers patients sous chloroquine se sont rétablis].

Dernière mise à jour : 16 avril 2020

[France Culture - 24 mars 2020] - Chloroquine : le protocole Raoult.
[France Inter - 26 mars 2020] - Chloroquine : tout le monde est devenu épidémiologiste !
[France Culture - 18 mars 2020] - Chloroquine : un remède français contre le Covid-19 ?

Réseaux sociaux

Dernière mise à jour : 11 avril 2020